Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$593M |
| 2 |
Abbott
ABT
|
+$259M |
| 3 |
AutoZone
AZO
|
+$204M |
| 4 |
AABA
Altaba Inc
AABA
|
+$186M |
| 5 |
D.R. Horton
DHI
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$215M |
| 2 |
Public Service Enterprise Group
PEG
|
+$211M |
| 3 |
Applied Materials
AMAT
|
+$203M |
| 4 |
Intuitive Surgical
ISRG
|
+$194M |
| 5 |
ConocoPhillips
COP
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.49% |
| 2 | Technology | 12.13% |
| 3 | Healthcare | 11.89% |
| 4 | Consumer Discretionary | 11.58% |
| 5 | Industrials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
United Natural Foods
UNFI
$2.88B
| $514K | ﹤0.01% |
10,438
-604,017
| -98% | -$26.4M |
|
|
HQH
3077
abrdn Healthcare Investors
HQH
$1.35B
| $513K | ﹤0.01% |
22,767
+11,718
| +106% | +$274K |
|
|
WRK
3078
DELISTED
WestRock Company
WRK
| $513K | ﹤0.01% |
8,112
-2,330,398
| -100% | -$141M |
|
3079
Oil-Dri
ODC
$1.33B
| $512K | ﹤0.01% |
24,656
+2,314
| +10% | +$50.8K |
|
3080
Schwab US Large-Cap Growth ETF
SCHG
$62.3B
| $510K | ﹤0.01% |
57,688
-11,088
| -16% | -$95.3K |
|
3081
CTS Corp
CTS
$1.62B
| $509K | ﹤0.01% |
+19,774
| New | +$520K |
|
3082
Veritone
VERI
$87.4M
| $509K | ﹤0.01% |
21,944
+3,149
| +17% | +$93.7K |
|
3083
Ichor Holdings
ICHR
$2.14B
| $508K | ﹤0.01% |
+20,662
| New | +$586K |
|
|
IGR
3084
CBRE Global Real Estate Income Fund
IGR
$712M
| $507K | ﹤0.01% |
64,026
+30,626
| +92% | +$240K |
|
3085
Hawaiian Electric Industries
HE
$1.96B
| $505K | ﹤0.01% |
+13,971
| New | +$506K |
|
3086
Knowles
KN
$2.87B
| $503K | ﹤0.01% |
34,282
-62,986
| -65% | -$984K |
|
3087
Medpace
MEDP
$17.1B
| $502K | ﹤0.01% |
13,854
-81,772
| -86% | -$2.87M |
|
|
PTLA
3088
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $501K | ﹤0.01% |
10,301
-433,281
| -98% | -$21.9M |
|
3089
Clarus
CLAR
$145M
| $499K | ﹤0.01% |
63,891
+21,828
| +52% | +$164K |
|
3090
United States Lime & Minerals
USLM
$3.42B
| $497K | ﹤0.01% |
32,235
+18,485
| +134% | +$319K |
|
|
PAK
3091
DELISTED
Global X MSCI Pakistan ETF
PAK
| $495K | ﹤0.01% |
10,000
-2,500
| -20% | -$137K |
|
3092
First Trust Utilities AlphaDEX Fund
FXU
$806M
| $494K | ﹤0.01% |
+18,999
| New | +$515K |
|
3093
Kaiser Aluminum
KALU
$2.51B
| $494K | ﹤0.01% |
4,621
-8,096
| -64% | -$810K |
|
|
ATRI
3094
DELISTED
Atrion Corp
ATRI
| $494K | ﹤0.01% |
784
+384
| +96% | +$251K |
|
|
ONIT
3095
Onity Group
ONIT
$294M
| $492K | ﹤0.01% |
10,469
+7,282
| +228% | +$365K |
|
|
UN
3096
DELISTED
Unilever NV New York Registry Shares
UN
| $492K | ﹤0.01% |
8,742
-11,428
| -57% | -$659K |
|
3097
ESCO Technologies
ESE
$7.17B
| $490K | ﹤0.01% |
+8,129
| New | +$494K |
|
3098
NVIDIA
NVDA
$5.16T
| $490K | ﹤0.01% |
101,240
-6,006,360
| -98% | -$29.8M |
|
|
SBB
3099
DELISTED
SUSSEX BANCORP
SBB
| $489K | ﹤0.01% |
+18,212
| New | +$489K |
|
|
STK
3100
Columbia Seligman Premium Technology Growth Fund
STK
$918M
| $488K | ﹤0.01% |
21,922
+10,213
| +87% | +$235K |
|
Similar funds
Israel Englander's Q4 2017 Portfolio in Review
As of Q4 2017, Israel Englander held 4,357 positions worth $72.5B, up 10% from $65.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander deployed $3.05B of net new capital in Q4 2017, opening 897 new positions and adding to 1,473 existing holdings. Its largest new stake was Viatris: 2,905,317 shares worth $123M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Honeywell, an estimated $215M trimmed.
- Israel Englander's largest Q4 2017 buy was Viatris: 2,905,317 shares worth $123M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $593M increase.
- Israel Englander's biggest Q4 2017 reduction was Honeywell, cutting an estimated $215M.
- Israel Englander fully exited Paychex in Q4 2017, selling an estimated $66.4M.
- Israel Englander's ten largest holdings make up 6.7% of its $72.5B portfolio in Q4 2017.
- Israel Englander opened 897 new positions and closed 601 in Q4 2017.
- Israel Englander's portfolio value rose 10% quarter-over-quarter to $72.5B.
Based on Millennium Management's 13F filing for Q4 2017, filed 14 Feb 2018.